Liver transplantation for neuroendocrine tumors

Journal of Gastrointestinal Surgery

Volumn 8, Issue 2, 2004, Pages 208-212

  Florman, Sander ^a,b   Toure, Ben ^a   Kim, Leona ^a   Gondolesi, Gabriel ^a   Roayaie, Sasan ^a   Krieger, Nancy ^a   Fishbein, Thomas ^a   Emre, Sukru ^a   Miller, Charles ^a   Schwartz, Myron ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

Cancer; Liver; Neuroendocrine; Transplantation

Indexed keywords

CARCINOID; FOLLOW UP; HEPATITIS; HUMAN; LIVER FAILURE; LIVER GRAFT; LIVER METASTASIS; LIVER TRANSPLANTATION; LOBECTOMY; METASTASIS; NEUROENDOCRINE TUMOR; REVIEW; SURVIVAL RATE; VIPOMA;

EID: 10744222408     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2003.11.010     Document Type: Article

References (25)

1. Soreide O., Berstad T., Bakka A., Schrumpf E., Hanssen L.E., Engh V., Bergan A., Flatmark A. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery. 111:1992;48-54.
2. Moertel C.G. Karnofsky memorial lecture: An odyssey in the land of small tumors. J Clin Oncol. 5:1987;1502-1503.
3. Thompson G.B., van Heerden J.A., Grant C.S., Carney J.A., Ilstrup D.M. Islet cell carcinomas of the pancreas: A twenty year experience. Surgery. 104:1988;1011-1017.
4. Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc. 20:1988;478-482.
5. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 110:1991;726-734.
6. Curtiss S.I., Mor E., Schwartz M.E., Sung M.W., Hytiroglou P., Thung S.N., Sheiner P.A., Emre S., Miller C.M. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg. 180:1995;184-187.
7. Olausson M., Friman S., Cahlin C., Nilsson O., Jansson S., Wangberg B., Ahlman H. Indications and results of liver transplantation in patients with neuroendocrine tumours. World J Surg. 26:2002;998-1004.
8. Rosenau J., Bahr M.J., von Wasielewski R., Mengel M., Schmidt H.H.J., Nashan B., Lang H., Klempnauer J., Manns M., Boeker K.H.W. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation. 73:2002;386-394.
9. Alessiani M., Tzakis A., Todo S., Demetris A.J., Fung J.J., Starzl T.E. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 180:1995;88-89.
10. Ringe B., Lorf T., Dopkens K., Canelo R. Treatment of hepatic metastases from gastroenteropancreatic neuroendocrine tumors: Role of liver transplantation. World J Surg. 25:2001;697-699.
11. Coppa J., Pulvirenti A., Schiavo M., Romito R., Collini P., Di Bartolomeo M., Fabbri A., Regalia E., Mazzaferro V. Resection versus transplantation for liver metastases from neuroendocrine tumors. Transplant Proc. 33:2001;1537-1539.
12. Pascher A., Steinmullr T., Radke C., Hosten N., Wiedenmann B., Neuhaus P., Bechstein W.O. Primary and secondary hepatic manifestation of neuroendocrine tumors. Langenbecks Arch Surg. 385:2000;265-270.
13. Frilling A., Rogiers X., Malago M., Liedke O., Kaun M., Broelsch C.E. Liver transplantation in patients with liver metastases of neuroendocrine tumors. Transplant Proc. 30:1998;3298-3300.
14. Dousset B., Saint-Marc O., Pitre J., Soubrane O., Houssin D., Chapuis Y. Metastatic endocrine tumors: Medical treatment, surgical resection, or liver transplantation. World J Surg. 20:1996;908-915.
15. Anthuber M., Jauch K.-W., Briegel J., Groh J., Schildberg F.W. Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg. 20:1996;73-76.
16. Routley D., Ramage J.K., McPeake J., Tan K.C., Williams R. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transpl Surg. 1:1995;118-121.
17. Arnold J.C., O'Grady J.G., Bird G.L., Calne R.Y., Williams R. Liver transplantation for primary and secondary hepatic apudomas. Br J Surg. 76:1989;248-249.
18. Makowka L., Tzakis A.G., Mazzaferro V., Teperman L., Demetris A.J., Iwatsuki S., Starzl T.E. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet. 168:1989;107-111.
19. Le Truet Y.P., Delpero J.R., Dousset B., Cherqui D., Segol P., Mantion G., Hannoun L., Benhamou G., Launois B., Boillot O., Domergue J., Bismuth H. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. Ann Sug. 225:1997;355-364.
20. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma. Transplantation. 66:1998;1307-1312.
21. Chamberlain R.S., Canes D., Brown K.T., Saltz L., Jamagin W., Fong Y., Blumgart L.H. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg. 190:2000;432-445.
22. Havelaar I.J., Sugarbaker P.H., Vermess M., Miller D.L. Rate of growth of intraabdominal metastases from colorectal cancer. Cancer. 54:1984;163-171.
23. Hara Y., Ogata Y., Shirouzu K. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis. J Exp Clin Cancer Res. 19:2000;497-504.
24. Stridsberg M., Öberg K., Li Q., Engstrom U., Lundqvist G. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreostatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol. 144:1995;49-59.
25. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Themeau T.M., Kosberg C.L., D'Amico G., Dickson E.R., Kim W.R. A model to predict survival in patients with end-stage liver disease. Hepatology. 33:2001;464-470.